2m 2m 2m 2m 2m 2m 2m
Inhibrx Bio (INBX)
NASDAQ
$82.26+$0.21 (+0.26%)
Price as of Aug 03, 2026 5:50 AM EDT- $1.2BMarket Cap
- 279.86%1-Year Change
- BiotechnologyIndustry
Inhibrx Bio (INBX)
$82.26+$0.21 (+0.26%)
INBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $82.05 | ||
Change | -$2.68 (-3.16%) | ||
Open | $85.63 | ||
High | $85.63 | ||
Low | $80.35 | ||
Previous Close | $84.73 | ||
Volume | 108,272 | ||
30-Day Average Volume | 291,948 | ||
1-Week Change | 0.61% | ||
1-Month Change | -13.40% | ||
1-Year Change | 279.86% | ||
3-Year Change | 309.23% | ||
5-Year Change | 188.30% | ||
Fundamentals | |||
Shares Outstanding | 14.7M | ||
Total Assets | $184.0M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$33.4M | ||
Free Cash Flow | -$38.0M | ||
EBIT | -$29.9M | ||
EBITDA | -$29.4M | ||
Net Working Capital | $144.8M | ||
EPS | -$2.15 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -57 | ||
P/E | -38 | ||
PEG | 22 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue